Emerson Electric Co. (EMR) Intrinsic Value

DCF-based fair value calculation with Bear, Base, and Bull scenarios

Popular:

Emerson Electric Co. (EMR)

View Full Profile →

Intrinsic Value (DCF)

Current$148.02
Intrinsic$70.63
-52%
$40.40$70.63$130.81
Market implies 23% growth for 5 years
Current price reflects execution expectations above 8% growth — not unreasonable for quality businesses.
At $148, the market prices in continued strong cash flow growth (23%) — likely reflecting buybacks, margin stability, and ecosystem strength.
Range: Bear $40 → Bull $131. Current price implies expectations above the base case, closer to bull expectations.
Discount ↓Growth →4%6%8%10%
8%$91$101$113$125
10%$56$63$71$79
12%$38$43$48$54
14%$27$31$35$39

Bull Case

  • Bull case ($131) with 10% growth, 8% discount rate
  • Conservative 8% growth assumption is achievable based on track record

Bear Case

  • Bear case ($40) implies 73% downside at 6% growth, 12% discount
  • Price reflects 23% growth expectations vs 8% historical — high bar to clear
  • Trading 52% above base case — execution must exceed assumptions to justify
Loading charts...

5-Year Free Cash Flow Projection

Year 1$2.88B
Year 2$3.11B
Year 3$3.36B
Year 4$3.63B
Year 5$3.92B
Terminal$62.10B

📐 Model Inputs

Growth Rate8.0%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate9.5%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Free Cash Flow$2.67BTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
ℹ️

DCF estimates based on historical growth rates extrapolated forward. See FAQ below for full methodology.

Frequently Asked Questions

Is EMR stock undervalued or overvalued?
🔴 OVERVALUED

EMR trades at $148.02 vs. our DCF-derived intrinsic value of $70.63, implying -51% downside. Using a 9.5% WACC and 8.0% FCF growth assumption, the current price requires growth rates above our estimates to be justified. Even our bull case ($107.39) suggests limited upside.

What is EMR's intrinsic value?

Using a 5-year DCF model: Base FCF of $2.67B, projected at 8.0% 5Y CAGR (best of revenue, EPS, or FCF growth), discounted at 9.5% WACC, with 3.0% terminal growth. Terminal value calculated via Gordon Growth Model: TV = FCF₅ × (1+g) / (WACC−g). After deducting $12.21B net debt and dividing by 0.57B shares: Bear $44.06 | Base $70.63 | Bull $107.39. Current price $148.02 implies -51% to base case.

How is EMR's fair value calculated?

DCF Methodology:

① Project FCF years 1-5 using 8.0% growth derived from 5-year historical CAGR (best of revenue, EPS, or FCF growth, with 8% floor and 25% cap).

② Calculate terminal value at year 5 using perpetuity growth model with g=3.0%.

③ Discount all cash flows to PV using WACC=9.5%.

④ Sum PV of explicit period + PV of terminal value = Enterprise Value ($52.24B).

⑤ Subtract net debt, divide by shares outstanding.

Sensitivity analysis available above—adjust WACC ±2% or growth ±3% to stress-test the valuation. Implied EV/FCF multiple: 19.6x.